abrdn Life Sciences Investors
HQL US87911K1007
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Saba Capital Management, L.p. |
14.14 USD |
41,623 Sold |
588,549 USD |
19/09/2025 | 22/09/2025 |
Saba Capital Management, L.p. |
14.10 USD |
6,989 Sold |
98,545 USD |
19/09/2025 | 19/09/2025 |
Saba Capital Management, L.p. |
14.10 USD |
6,989 Sold |
98,545 USD |
19/09/2025 | 19/09/2025 |
Saba Capital Management, L.p. |
14.07 USD |
40,208 Sold |
565,727 USD |
17/09/2025 | 18/09/2025 |
Saba Capital Management, L.p. |
13.99 USD |
24,328 Sold |
340,349 USD |
17/09/2025 | 17/09/2025 |
Saba Capital Management, L.p. |
13.99 USD |
2,026 Sold |
28,344 USD |
15/09/2025 | 16/09/2025 |
Saba Capital Management, L.p. |
14.13 USD |
700 Sold |
9,891 USD |
15/09/2025 | 15/09/2025 |
Saba Capital Management, L.p. |
14.28 USD |
15,116 Sold |
215,856 USD |
11/09/2025 | 11/09/2025 |
Maher Bill O |
15.37 USD |
650 Bought |
9,991 USD |
23/08/2024 | 23/08/2024 |
Dimartino Rose O |
15.53 USD |
1,000 Bought |
15,530 USD |
16/07/2024 | 16/07/2024 |